Zomedica Corp Ordinary Shares ZOM
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ZOM is a good fit for your portfolio.
News
-
Zomedica Announces First Quarter 2024 Financial Results: Revenue up 14% to $6.3 Million; 66% Gross Margin, and $91 Million in Liquidity
-
Zomedica to Present at the EF Hutton Annual Global Conference on May 15, 2024
-
Zomedica Expands International Reach with CE Certification for VetGuardian(R) System
-
Zomedica Strengthens Market Position with New Patents Issued for its TRUFORMA(R) Diagnostic Platform
-
Zomedica to Report First Quarter 2024 Financial Results and Provide Business Update on May 9th at 4:30 p.m. ET
-
Zomedica to Present at the Noble Capital Markets Virtual Healthcare Conference on April 17, 2024
-
Zomedica Reports Record Revenue of $7.3 Million for the Fourth Quarter and $25.2 Million for the Full Year 2023, Reflecting 33% Annual Growth; 69% Gross Margin and $100.5 Million in Liquidity
-
Zomedica to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Monday, April 1, 2024, at 4:30 p.m. ET
Trading Information
- Previous Close Price
- $0.16
- Day Range
- $0.14–0.15
- 52-Week Range
- $0.12–0.25
- Bid/Ask
- $0.14 / $0.14
- Market Cap
- $133.37 Mil
- Volume/Avg
- 6.0 Mil / 5.2 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 6.18
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Zomedica Corp is a veterinary health company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians. The company's product portfolio includes diagnostics and therapeutics that emphasize patient health and practice health. The company is focused on the final development and commercialization of its TRUFORMA platform, which detects thyroid disorders in dogs & cats and adrenal disorders in dogs. Its operations are comprised of two reportable segments namely Diagnostic and Therapeutics devices. It earns the majority of revenue from the therapeutics segment.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 144
- Website
- https://www.zomedica.com
Comparables
Valuation
|
Metric
|
ZOM
|
BLU
|
VCYT
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | 24.03 |
Price/Book Value | 0.65 | 5.83 | 1.41 |
Price/Sales | 6.18 | — | 4.02 |
Price/Cash Flow | — | — | 28.01 |
Price/Earnings
ZOM
BLU
VCYT
Financial Strength
|
Metric
|
ZOM
|
BLU
|
VCYT
|
|---|---|---|---|
Quick Ratio | 10.26 | 32.13 | 4.41 |
Current Ratio | 11.06 | 33.42 | 5.00 |
Interest Coverage | −235.10 | −1,125.80 | −11,324.57 |
Quick Ratio
ZOM
BLU
VCYT
Profitability
|
Metric
|
ZOM
|
BLU
|
VCYT
|
|---|---|---|---|
Return on Assets (Normalized) | −7.20% | −21.75% | 8.19% |
Return on Equity (Normalized) | −7.59% | −26.24% | 8.76% |
Return on Invested Capital (Normalized) | −9.50% | −24.47% | 7.87% |
Return on Assets
ZOM
BLU
VCYT
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Dltwgzfj | Ptyqxm | $182.6 Bil | |
SYK
| Stryker Corp | Bqvwynxm | Xfvj | $126.0 Bil | |
MDT
| Medtronic PLC | Jrxzydkz | Jtyzm | $108.3 Bil | |
BSX
| Boston Scientific Corp | Qvvmbbwh | Fmpym | $106.9 Bil | |
EW
| Edwards Lifesciences Corp | Nmdmkqvgg | Vhvhx | $51.7 Bil | |
DXCM
| DexCom Inc | Vpwmclsvt | Pvwv | $50.8 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Tdkyknvps | Rsfn | $24.9 Bil | |
PHG
| Koninklijke Philips NV ADR | Vnpndgkdz | Jhsdhy | $23.9 Bil | |
ALGN
| Align Technology Inc | Yrsxvnpp | Mmtrht | $21.1 Bil | |
PODD
| Insulet Corp | Hmbzzvrtyq | Bpfygl | $12.4 Bil |